Herein, we scanned the genome to detect polymorphisms mediating risk for T2DM-ESRD, conditional on APOL1 G1/G2 nephropathy risk variants and the MYH9 E1 risk haplotype using case-control and case-only study designs. The gene discussed is APOL1; the disease is kidney disorder.